

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | central nervous system myelination (GO:0022010) | 4.34340403 |
| 2 | axon ensheathment in central nervous system (GO:0032291) | 4.34340403 |
| 3 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.82183346 |
| 4 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 3.79510701 |
| 5 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.68905121 |
| 6 | regulation of cell communication by electrical coupling (GO:0010649) | 3.62093530 |
| 7 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.61763197 |
| 8 | negative regulation of protein localization to cell surface (GO:2000009) | 3.58839165 |
| 9 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 3.56474908 |
| 10 | creatine metabolic process (GO:0006600) | 3.52541053 |
| 11 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.41443738 |
| 12 | negative regulation of potassium ion transmembrane transport (GO:1901380) | 3.39795024 |
| 13 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.36671975 |
| 14 | eye photoreceptor cell differentiation (GO:0001754) | 3.28960668 |
| 15 | photoreceptor cell differentiation (GO:0046530) | 3.28960668 |
| 16 | regulation of actin filament-based movement (GO:1903115) | 3.26524742 |
| 17 | regulation of ventricular cardiac muscle cell membrane repolarization (GO:0060307) | 3.25925890 |
| 18 | cardiac myofibril assembly (GO:0055003) | 3.22695399 |
| 19 | cell communication by electrical coupling involved in cardiac conduction (GO:0086064) | 3.21894163 |
| 20 | myelination (GO:0042552) | 3.20400708 |
| 21 | ensheathment of neurons (GO:0007272) | 3.18797069 |
| 22 | axon ensheathment (GO:0008366) | 3.18797069 |
| 23 | sarcomere organization (GO:0045214) | 3.16422955 |
| 24 | regulation of relaxation of muscle (GO:1901077) | 3.15793677 |
| 25 | membrane depolarization during cardiac muscle cell action potential (GO:0086012) | 3.14142555 |
| 26 | myofibril assembly (GO:0030239) | 3.10758246 |
| 27 | cellular response to epinephrine stimulus (GO:0071872) | 3.02380372 |
| 28 | potassium ion import (GO:0010107) | 3.00560140 |
| 29 | regulation of membrane repolarization (GO:0060306) | 2.99185702 |
| 30 | positive regulation of potassium ion transmembrane transporter activity (GO:1901018) | 2.96916210 |
| 31 | neuron cell-cell adhesion (GO:0007158) | 2.96029923 |
| 32 | establishment of mitochondrion localization (GO:0051654) | 2.92921291 |
| 33 | regulation of voltage-gated calcium channel activity (GO:1901385) | 2.91466340 |
| 34 | response to epinephrine (GO:0071871) | 2.91025344 |
| 35 | behavioral response to nicotine (GO:0035095) | 2.90300049 |
| 36 | regulation of calcium ion transmembrane transport (GO:1903169) | 2.89931216 |
| 37 | regulation of calcium ion transmembrane transporter activity (GO:1901019) | 2.89931216 |
| 38 | neuronal action potential propagation (GO:0019227) | 2.89859831 |
| 39 | regulation of cardiac muscle cell contraction (GO:0086004) | 2.89253640 |
| 40 | regulation of acetyl-CoA biosynthetic process from pyruvate (GO:0010510) | 2.86719874 |
| 41 | cell communication by electrical coupling (GO:0010644) | 2.83295985 |
| 42 | presynaptic membrane assembly (GO:0097105) | 2.82679634 |
| 43 | detection of calcium ion (GO:0005513) | 2.79413510 |
| 44 | synaptic vesicle maturation (GO:0016188) | 2.78822455 |
| 45 | regulation of skeletal muscle contraction (GO:0014819) | 2.78346638 |
| 46 | presynaptic membrane organization (GO:0097090) | 2.77317556 |
| 47 | regulation of acyl-CoA biosynthetic process (GO:0050812) | 2.76773196 |
| 48 | muscle filament sliding (GO:0030049) | 2.76540076 |
| 49 | actin-myosin filament sliding (GO:0033275) | 2.76540076 |
| 50 | cell communication involved in cardiac conduction (GO:0086065) | 2.75685749 |
| 51 | fatty acid elongation (GO:0030497) | 2.75642299 |
| 52 | positive regulation of excitatory postsynaptic membrane potential (GO:2000463) | 2.75473507 |
| 53 | adult heart development (GO:0007512) | 2.75013496 |
| 54 | cardiac muscle contraction (GO:0060048) | 2.74982251 |
| 55 | regulation of sequestering of triglyceride (GO:0010889) | 2.74937757 |
| 56 | positive regulation of calcium ion-dependent exocytosis (GO:0045956) | 2.71204071 |
| 57 | kidney morphogenesis (GO:0060993) | 2.70474332 |
| 58 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.70096385 |
| 59 | locomotory exploration behavior (GO:0035641) | 2.69183468 |
| 60 | regulation of striated muscle contraction (GO:0006942) | 2.68248578 |
| 61 | positive regulation of potassium ion transport (GO:0043268) | 2.67940760 |
| 62 | positive regulation of action potential (GO:0045760) | 2.66123474 |
| 63 | regulation of glucokinase activity (GO:0033131) | 2.64867698 |
| 64 | regulation of hexokinase activity (GO:1903299) | 2.64867698 |
| 65 | membrane depolarization during action potential (GO:0086010) | 2.64836699 |
| 66 | regulation of short-term neuronal synaptic plasticity (GO:0048172) | 2.64275692 |
| 67 | regulation of atrial cardiac muscle cell membrane depolarization (GO:0060371) | 2.63345266 |
| 68 | regulation of mesoderm development (GO:2000380) | 2.62696362 |
| 69 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 2.62517807 |
| 70 | cardiac muscle cell action potential (GO:0086001) | 2.61946070 |
| 71 | regulation of action potential (GO:0098900) | 2.60844527 |
| 72 | actomyosin structure organization (GO:0031032) | 2.59963174 |
| 73 | vocalization behavior (GO:0071625) | 2.59930171 |
| 74 | regulation of cardiac muscle contraction (GO:0055117) | 2.59823718 |
| 75 | positive regulation of potassium ion transmembrane transport (GO:1901381) | 2.59741611 |
| 76 | ventricular cardiac muscle cell action potential (GO:0086005) | 2.57619958 |
| 77 | plasma membrane repair (GO:0001778) | 2.57619778 |
| 78 | cornea development in camera-type eye (GO:0061303) | 2.57432343 |
| 79 | cellular response to monoamine stimulus (GO:0071868) | 2.57234378 |
| 80 | cellular response to catecholamine stimulus (GO:0071870) | 2.57234378 |
| 81 | cardiac muscle hypertrophy (GO:0003300) | 2.56400947 |
| 82 | neuron recognition (GO:0008038) | 2.56103860 |
| 83 | negative regulation of hormone biosynthetic process (GO:0032353) | 2.55200332 |
| 84 | negative regulation of neurotransmitter secretion (GO:0046929) | 2.54891959 |
| 85 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 2.53340799 |
| 86 | negative regulation of neurotransmitter transport (GO:0051589) | 2.53157868 |
| 87 | protein localization to synapse (GO:0035418) | 2.52040884 |
| 88 | cardiac muscle cell action potential involved in contraction (GO:0086002) | 2.51374635 |
| 89 | positive regulation of glomerulus development (GO:0090193) | 2.50878486 |
| 90 | transmission of nerve impulse (GO:0019226) | 2.49379677 |
| 91 | adrenergic receptor signaling pathway (GO:0071875) | 2.48867346 |
| 92 | regulation of sarcomere organization (GO:0060297) | 2.48453591 |
| 93 | regulation of cofactor metabolic process (GO:0051193) | 2.48199444 |
| 94 | regulation of coenzyme metabolic process (GO:0051196) | 2.48199444 |
| 95 | cellular potassium ion homeostasis (GO:0030007) | 2.48173411 |
| 96 | positive regulation of heart rate (GO:0010460) | 2.47659320 |
| 97 | regulation of synapse structural plasticity (GO:0051823) | 2.47575686 |
| 98 | response to caffeine (GO:0031000) | 2.47332569 |
| 99 | regulation of inhibitory postsynaptic membrane potential (GO:0060080) | 2.47151904 |
| 100 | striated muscle hypertrophy (GO:0014897) | 2.46559290 |
| 101 | nerve growth factor signaling pathway (GO:0038180) | 2.46463261 |
| 102 | synaptic vesicle exocytosis (GO:0016079) | 2.46399510 |
| 103 | regulation of potassium ion transmembrane transporter activity (GO:1901016) | 2.46306829 |
| 104 | adult walking behavior (GO:0007628) | 2.46287787 |
| 105 | cardiac conduction (GO:0061337) | 2.45450634 |
| 106 | neuromuscular junction development (GO:0007528) | 2.45347366 |
| 107 | positive regulation of glycolytic process (GO:0045821) | 2.44903222 |
| 108 | fatty acid transmembrane transport (GO:1902001) | 2.44289311 |
| 109 | regulation of alpha-amino-3-hydroxy-5-methyl-4-isoxazole propionate selective glutamate receptor act | 2.43907614 |
| 110 | regulation of potassium ion transmembrane transport (GO:1901379) | 2.43720318 |
| 111 | regulation of cation channel activity (GO:2001257) | 2.43334415 |
| 112 | response to monoamine (GO:0071867) | 2.43148739 |
| 113 | response to catecholamine (GO:0071869) | 2.43148739 |
| 114 | cerebellar granule cell differentiation (GO:0021707) | 2.42096224 |
| 115 | striated muscle contraction (GO:0006941) | 2.41825888 |
| 116 | carnitine shuttle (GO:0006853) | 2.41601077 |
| 117 | membrane tubulation (GO:0097320) | 2.41306817 |
| 118 | regulation of heart rate (GO:0002027) | 2.40372905 |
| 119 | ionotropic glutamate receptor signaling pathway (GO:0035235) | 2.39845644 |
| 120 | cardiac right ventricle morphogenesis (GO:0003215) | 2.39488913 |
| 121 | tricarboxylic acid cycle (GO:0006099) | 2.37937729 |
| 122 | somite development (GO:0061053) | 2.37194450 |
| 123 | regulation of type B pancreatic cell apoptotic process (GO:2000674) | 2.37120556 |
| 124 | dendrite morphogenesis (GO:0048813) | 2.36613701 |
| 125 | apical protein localization (GO:0045176) | 2.36566504 |
| 126 | positive regulation of cardiac muscle cell differentiation (GO:2000727) | 2.36521073 |
| 127 | actin-mediated cell contraction (GO:0070252) | 2.36458042 |
| 128 | regulation of rhodopsin mediated signaling pathway (GO:0022400) | 2.36447002 |
| 129 | negative regulation of cytosolic calcium ion concentration (GO:0051481) | 2.35963871 |
| 130 | dendritic spine morphogenesis (GO:0060997) | 2.35954060 |
| 131 | regulation of dendritic spine morphogenesis (GO:0061001) | 2.35948179 |
| 132 | regulation of the force of heart contraction (GO:0002026) | 2.35228675 |
| 133 | cardiac muscle cell development (GO:0055013) | 2.34843697 |
| 134 | positive regulation of sodium ion transport (GO:0010765) | 2.32218914 |
| 135 | regulation of heart rate by cardiac conduction (GO:0086091) | 2.31718351 |
| 136 | action potential (GO:0001508) | 2.31088855 |
| 137 | relaxation of cardiac muscle (GO:0055119) | 2.30982879 |
| 138 | calcium ion import (GO:0070509) | 2.29394840 |
| 139 | positive regulation of phosphoprotein phosphatase activity (GO:0032516) | 2.25867080 |
| 140 | multicellular organismal signaling (GO:0035637) | 2.25498293 |
| 141 | cardiac muscle tissue morphogenesis (GO:0055008) | 2.23982150 |
| 142 | muscle fiber development (GO:0048747) | 2.23331357 |
| 143 | negative regulation of calcium ion-dependent exocytosis (GO:0045955) | 2.22830666 |
| 144 | negative regulation of hormone metabolic process (GO:0032351) | 2.21810557 |
| 145 | adenylate cyclase-activating dopamine receptor signaling pathway (GO:0007191) | 2.21586257 |
| 146 | cardiac cell development (GO:0055006) | 2.18607182 |
| 147 | lipid particle organization (GO:0034389) | 2.17957791 |
| 148 | regulation of acrosome reaction (GO:0060046) | 2.17718176 |
| 149 | otic vesicle formation (GO:0030916) | 2.17022213 |
| 150 | lateral sprouting from an epithelium (GO:0060601) | 2.16622207 |
| 151 | insulin secretion (GO:0030073) | 2.14863407 |
| 152 | regulation of gene silencing by RNA (GO:0060966) | 2.13421553 |
| 153 | regulation of posttranscriptional gene silencing (GO:0060147) | 2.13421553 |
| 154 | regulation of gene silencing by miRNA (GO:0060964) | 2.13421553 |
| 155 | cAMP catabolic process (GO:0006198) | 2.11764772 |
| 156 | regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway (GO:1902235 | 2.11120083 |
| 157 | response to inactivity (GO:0014854) | 2.10738429 |
| 158 | behavioral response to ethanol (GO:0048149) | 2.10299618 |
| 159 | neuronal action potential (GO:0019228) | 2.09545344 |
| 160 | cell migration involved in gastrulation (GO:0042074) | 2.08221177 |
| 161 | bundle of His cell to Purkinje myocyte communication (GO:0086069) | 2.07912190 |
| 162 | fatty acid homeostasis (GO:0055089) | 2.07847267 |
| 163 | positive regulation of cation channel activity (GO:2001259) | 2.07734829 |
| 164 | lung-associated mesenchyme development (GO:0060484) | 2.07635638 |
| 165 | muscle tissue morphogenesis (GO:0060415) | 2.04501933 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | EZH2_22144423_ChIP-Seq_EOC_Human | 3.97112354 |
| 2 | GBX2_23144817_ChIP-Seq_PC3_Human | 3.27325677 |
| 3 | * SUZ12_18555785_ChIP-Seq_MESCs_Mouse | 2.65058582 |
| 4 | * SUZ12_18692474_ChIP-Seq_MESCs_Mouse | 2.58889656 |
| 5 | JARID2_20064375_ChIP-Seq_MESCs_Mouse | 2.44374267 |
| 6 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.35883523 |
| 7 | * EZH2_18974828_ChIP-Seq_MESCs_Mouse | 2.34518305 |
| 8 | * RNF2_18974828_ChIP-Seq_MESCs_Mouse | 2.34518305 |
| 9 | * SUZ12_18692474_ChIP-Seq_MEFs_Mouse | 2.23302119 |
| 10 | * MTF2_20144788_ChIP-Seq_MESCs_Mouse | 2.19820744 |
| 11 | EZH2_27304074_Chip-Seq_ESCs_Mouse | 2.18271263 |
| 12 | DROSHA_22980978_ChIP-Seq_HELA_Human | 2.10281686 |
| 13 | * SUZ12_18974828_ChIP-Seq_MESCs_Mouse | 2.08255026 |
| 14 | SUZ12_16625203_ChIP-ChIP_MESCs_Mouse | 2.04834299 |
| 15 | * SUZ12_20075857_ChIP-Seq_MESCs_Mouse | 2.04609681 |
| 16 | JARID2_20075857_ChIP-Seq_MESCs_Mouse | 2.02413860 |
| 17 | * EP300_21415370_ChIP-Seq_HL-1_Mouse | 2.00285206 |
| 18 | FOXP1_22492998_ChIP-Seq_STRATIUM_Mouse | 1.98102565 |
| 19 | EED_16625203_ChIP-ChIP_MESCs_Mouse | 1.97060346 |
| 20 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 1.95695334 |
| 21 | * EZH2_27294783_Chip-Seq_ESCs_Mouse | 1.93997409 |
| 22 | FLI1_27457419_Chip-Seq_LIVER_Mouse | 1.90176548 |
| 23 | AR_21572438_ChIP-Seq_LNCaP_Human | 1.86976707 |
| 24 | SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.84473057 |
| 25 | * SUZ12_27294783_Chip-Seq_ESCs_Mouse | 1.80633355 |
| 26 | TAF15_26573619_Chip-Seq_HEK293_Human | 1.76616266 |
| 27 | * RNF2_27304074_Chip-Seq_ESCs_Mouse | 1.70989452 |
| 28 | PCGF2_27294783_Chip-Seq_ESCs_Mouse | 1.63869304 |
| 29 | * RARB_27405468_Chip-Seq_BRAIN_Mouse | 1.56216317 |
| 30 | MEIS1_26253404_ChIP-Seq_OPTIC_CUPS_Mouse | 1.55600149 |
| 31 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.54456958 |
| 32 | * PAX3-FKHR_20663909_ChIP-Seq_RHABDOMYOSARCOMA_Human | 1.53207123 |
| 33 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.49415083 |
| 34 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.49017459 |
| 35 | CTBP1_25329375_ChIP-Seq_LNCAP_Human | 1.45953187 |
| 36 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.45307438 |
| 37 | REST_21632747_ChIP-Seq_MESCs_Mouse | 1.42487029 |
| 38 | PHC1_16625203_ChIP-ChIP_MESCs_Mouse | 1.42432483 |
| 39 | ZFP57_27257070_Chip-Seq_ESCs_Mouse | 1.42352662 |
| 40 | CTBP2_25329375_ChIP-Seq_LNCAP_Human | 1.42088507 |
| 41 | POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.41693772 |
| 42 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 1.41333392 |
| 43 | SMAD4_21799915_ChIP-Seq_A2780_Human | 1.41116683 |
| 44 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 1.40064638 |
| 45 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.38536077 |
| 46 | SALL1_21062744_ChIP-ChIP_HESCs_Human | 1.36979516 |
| 47 | EWS_26573619_Chip-Seq_HEK293_Human | 1.34048323 |
| 48 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 1.33852115 |
| 49 | NR4A2_19515692_ChIP-ChIP_MN9D_Mouse | 1.33221525 |
| 50 | NR3C1_23031785_ChIP-Seq_PC12_Mouse | 1.31951986 |
| 51 | * SMAD3_21741376_ChIP-Seq_EPCs_Human | 1.30533980 |
| 52 | IRF4_20064451_ChIP-Seq_CD4+T_Mouse | 1.30441410 |
| 53 | CBP_20019798_ChIP-Seq_JUKART_Human | 1.30441410 |
| 54 | SMAD2/3_21741376_ChIP-Seq_EPCs_Human | 1.29506736 |
| 55 | RNF2_27304074_Chip-Seq_NSC_Mouse | 1.28529589 |
| 56 | ZNF274_21170338_ChIP-Seq_K562_Hela | 1.27399661 |
| 57 | PCGF2_27294783_Chip-Seq_NPCs_Mouse | 1.27361391 |
| 58 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.27334417 |
| 59 | * SMARCD1_25818293_ChIP-Seq_ESCs_Mouse | 1.27052770 |
| 60 | RNF2_16625203_ChIP-ChIP_MESCs_Mouse | 1.26254496 |
| 61 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 1.25907149 |
| 62 | CBX2_27304074_Chip-Seq_ESCs_Mouse | 1.25460036 |
| 63 | SOX2_21211035_ChIP-Seq_LN229_Gbm | 1.25425905 |
| 64 | ER_23166858_ChIP-Seq_MCF-7_Human | 1.24623750 |
| 65 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.23041786 |
| 66 | NANOG_18555785_Chip-Seq_ESCs_Mouse | 1.22877508 |
| 67 | REST_18959480_ChIP-ChIP_MESCs_Mouse | 1.21224534 |
| 68 | STAT3_23295773_ChIP-Seq_U87_Human | 1.20448138 |
| 69 | P300_19829295_ChIP-Seq_ESCs_Human | 1.20110590 |
| 70 | WT1_25993318_ChIP-Seq_PODOCYTE_Human | 1.18095525 |
| 71 | KLF4_25985364_ChIP-Seq_ATHEROSCLEROSIS_LESION_Mouse | 1.16395148 |
| 72 | ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.16281568 |
| 73 | TEAD4_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.15984004 |
| 74 | POU5F1_26923725_Chip-Seq_MESODERM_Mouse | 1.15984004 |
| 75 | VDR_22108803_ChIP-Seq_LS180_Human | 1.15640616 |
| 76 | TOP2B_26459242_ChIP-Seq_MCF-7_Human | 1.14735414 |
| 77 | GLI1_17442700_ChIP-ChIP_MESCs_Mouse | 1.13942615 |
| 78 | EBF1_22473956_ChIP-Seq_BONE_MARROW_Mouse | 1.13439151 |
| 79 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.12999891 |
| 80 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.12999891 |
| 81 | EWS-FLI1_20517297_ChIP-Seq_SK-N-MC_Human | 1.12112168 |
| 82 | TRIM28_17542650_ChIP-ChIP_NTERA2_Human | 1.11179354 |
| 83 | TCF4_22108803_ChIP-Seq_LS180_Human | 1.11011277 |
| 84 | SMAD4_21741376_ChIP-Seq_EPCs_Human | 1.09547195 |
| 85 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.09468844 |
| 86 | LMO2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.09019869 |
| 87 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.08620047 |
| 88 | P53_22387025_ChIP-Seq_ESCs_Mouse | 1.08579387 |
| 89 | ZFP322A_24550733_ChIP-Seq_MESCs_Mouse | 1.08433872 |
| 90 | ARNT_22903824_ChIP-Seq_MCF-7_Human | 1.07497365 |
| 91 | KDM2B_26808549_Chip-Seq_REH_Human | 1.07012247 |
| 92 | FUS_26573619_Chip-Seq_HEK293_Human | 1.06624896 |
| 93 | BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 1.06026252 |
| 94 | EP300_20729851_ChIP-Seq_FORBRAIN_MIDBRAIN_LIMB_HEART_Mouse | 1.05836063 |
| 95 | NR3C1_21868756_ChIP-Seq_MCF10A_Human | 1.05703087 |
| 96 | CJUN_26792858_Chip-Seq_BT549_Human | 1.05618407 |
| 97 | TCF3/E2A_22897851_ChIP-Seq_JUKARTE6-1_Human | 1.04941628 |
| 98 | TCF4_23295773_ChIP-Seq_U87_Human | 1.04836331 |
| 99 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.04751333 |
| 100 | UBF1/2_26484160_Chip-Seq_FIBROBLAST_Human | 1.04693808 |
| 101 | AHR_22903824_ChIP-Seq_MCF-7_Human | 1.03700730 |
| 102 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.03449619 |
| 103 | RING1B_27294783_Chip-Seq_ESCs_Mouse | 1.03380008 |
| 104 | TP53_16413492_ChIP-PET_HCT116_Human | 1.03360339 |
| 105 | IGF1R_20145208_ChIP-Seq_DFB_Human | 1.03030682 |
| 106 | RCOR1_19997604_ChIP-ChIP_NEURONS_Mouse | 1.03018460 |
| 107 | AR_19668381_ChIP-Seq_PC3_Human | 1.02634949 |
| 108 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.02463713 |
| 109 | TAL1_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.01917538 |
| 110 | TAL1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 1.01318213 |
| 111 | TBX20_22328084_ChIP-Seq_HEART_Mouse | 0.99196457 |
| 112 | TBX20_22080862_ChIP-Seq_HEART_Mouse | 0.99196457 |
| 113 | * WT1_20215353_ChIP-ChIP_NEPHRON_PROGENITOR_Mouse | 0.98919548 |
| 114 | ESRRB_18555785_ChIP-Seq_MESCs_Mouse | 0.96128657 |
| 115 | AR_25329375_ChIP-Seq_VCAP_Human | 0.96069224 |
| 116 | P53_22127205_ChIP-Seq_FIBROBLAST_Human | 0.95580747 |
| 117 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 0.95158074 |
| 118 | MEIS1_26923725_Chip-Seq_HEMOGENIC-ENDOTHELIUM_Mouse | 0.95085539 |
| 119 | SMAD4_21741376_ChIP-Seq_HESCs_Human | 0.94909130 |
| 120 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.93947430 |
| 121 | BCAT_22108803_ChIP-Seq_LS180_Human | 0.93823218 |
| 122 | TFAP2C_20629094_ChIP-Seq_MCF-7_Human | 0.93611617 |
| 123 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 0.92886189 |
| 124 | * SMAD3_21741376_ChIP-Seq_HESCs_Human | 0.92844304 |
| 125 | CDKN2AIP_20523734_ChIP-Seq_CORTICAL_Neurons | 0.90879035 |
| 126 | YAP1_20516196_ChIP-Seq_MESCs_Mouse | 0.90705534 |
| 127 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 0.90281729 |
| 128 | PRDM14_20953172_ChIP-Seq_ESCs_Human | 0.90149077 |
| 129 | MYCN_19997598_ChIP-ChIP_NEUROBLASTOMA_Human | 0.90084046 |
| 130 | RUNX2_22187159_ChIP-Seq_PCA_Human | 0.87683568 |
| 131 | BMI1_23680149_ChIP-Seq_NPCS_Mouse | 0.86392672 |
| 132 | ERG_21242973_ChIP-ChIP_JURKAT_Human | 0.85534141 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | MP0002837_dystrophic_cardiac_calcinosis | 3.93537477 |
| 2 | MP0000751_myopathy | 3.40882126 |
| 3 | MP0004084_abnormal_cardiac_muscle | 2.85878242 |
| 4 | MP0004036_abnormal_muscle_relaxation | 2.83271389 |
| 5 | MP0003880_abnormal_central_pattern | 2.82827329 |
| 6 | MP0003283_abnormal_digestive_organ | 2.82302632 |
| 7 | MP0004215_abnormal_myocardial_fiber | 2.76556626 |
| 8 | MP0004145_abnormal_muscle_electrophysio | 2.72109896 |
| 9 | MP0003646_muscle_fatigue | 2.65595152 |
| 10 | MP0004270_analgesia | 2.55758011 |
| 11 | * MP0004859_abnormal_synaptic_plasticity | 2.51503672 |
| 12 | MP0002876_abnormal_thyroid_physiology | 2.41624674 |
| 13 | MP0000749_muscle_degeneration | 2.39535340 |
| 14 | MP0003950_abnormal_plasma_membrane | 2.27002241 |
| 15 | MP0005551_abnormal_eye_electrophysiolog | 2.18405691 |
| 16 | MP0004130_abnormal_muscle_cell | 2.15832833 |
| 17 | MP0000920_abnormal_myelination | 2.14941942 |
| 18 | MP0005330_cardiomyopathy | 2.14896950 |
| 19 | * MP0003635_abnormal_synaptic_transmissio | 2.08160379 |
| 20 | MP0003137_abnormal_impulse_conducting | 1.97267774 |
| 21 | MP0005620_abnormal_muscle_contractility | 1.88711251 |
| 22 | MP0002272_abnormal_nervous_system | 1.88065557 |
| 23 | MP0002064_seizures | 1.83084260 |
| 24 | MP0003195_calcinosis | 1.81417212 |
| 25 | MP0000747_muscle_weakness | 1.79375324 |
| 26 | MP0004087_abnormal_muscle_fiber | 1.78220979 |
| 27 | MP0002638_abnormal_pupillary_reflex | 1.77708809 |
| 28 | MP0009745_abnormal_behavioral_response | 1.76707537 |
| 29 | MP0009046_muscle_twitch | 1.76586763 |
| 30 | MP0004484_altered_response_of | 1.75272101 |
| 31 | MP0001486_abnormal_startle_reflex | 1.74123023 |
| 32 | MP0002972_abnormal_cardiac_muscle | 1.71931447 |
| 33 | MP0005646_abnormal_pituitary_gland | 1.68979829 |
| 34 | MP0004085_abnormal_heartbeat | 1.62800200 |
| 35 | MP0003329_amyloid_beta_deposits | 1.61072011 |
| 36 | MP0008775_abnormal_heart_ventricle | 1.60296883 |
| 37 | MP0001984_abnormal_olfaction | 1.57359659 |
| 38 | MP0002106_abnormal_muscle_physiology | 1.56509182 |
| 39 | MP0005423_abnormal_somatic_nervous | 1.55916853 |
| 40 | MP0002102_abnormal_ear_morphology | 1.54546877 |
| 41 | * MP0002063_abnormal_learning/memory/cond | 1.53071298 |
| 42 | MP0009780_abnormal_chondrocyte_physiolo | 1.49439642 |
| 43 | MP0003787_abnormal_imprinting | 1.48826529 |
| 44 | MP0008877_abnormal_DNA_methylation | 1.47986095 |
| 45 | MP0004043_abnormal_pH_regulation | 1.47779528 |
| 46 | MP0004885_abnormal_endolymph | 1.45560101 |
| 47 | MP0003690_abnormal_glial_cell | 1.44696667 |
| 48 | MP0000759_abnormal_skeletal_muscle | 1.44340280 |
| 49 | MP0008569_lethality_at_weaning | 1.44063300 |
| 50 | MP0005369_muscle_phenotype | 1.43163834 |
| 51 | MP0000013_abnormal_adipose_tissue | 1.42368248 |
| 52 | MP0006072_abnormal_retinal_apoptosis | 1.41931014 |
| 53 | MP0006276_abnormal_autonomic_nervous | 1.40259410 |
| 54 | MP0002734_abnormal_mechanical_nocicepti | 1.40006937 |
| 55 | MP0006138_congestive_heart_failure | 1.33469405 |
| 56 | MP0002572_abnormal_emotion/affect_behav | 1.33030689 |
| 57 | MP0000778_abnormal_nervous_system | 1.32380391 |
| 58 | MP0005253_abnormal_eye_physiology | 1.31534903 |
| 59 | MP0000372_irregular_coat_pigmentation | 1.30571038 |
| 60 | MP0004924_abnormal_behavior | 1.29139646 |
| 61 | MP0005386_behavior/neurological_phenoty | 1.29139646 |
| 62 | MP0005666_abnormal_adipose_tissue | 1.28395045 |
| 63 | MP0002909_abnormal_adrenal_gland | 1.25515818 |
| 64 | MP0001440_abnormal_grooming_behavior | 1.25287049 |
| 65 | MP0002067_abnormal_sensory_capabilities | 1.24808573 |
| 66 | * MP0002229_neurodegeneration | 1.24797883 |
| 67 | MP0003634_abnormal_glial_cell | 1.23390220 |
| 68 | MP0003011_delayed_dark_adaptation | 1.22799732 |
| 69 | MP0002269_muscular_atrophy | 1.22798916 |
| 70 | MP0005385_cardiovascular_system_phenoty | 1.21321264 |
| 71 | MP0001544_abnormal_cardiovascular_syste | 1.21321264 |
| 72 | MP0001529_abnormal_vocalization | 1.20878778 |
| 73 | MP0003122_maternal_imprinting | 1.19135572 |
| 74 | MP0004142_abnormal_muscle_tone | 1.17790117 |
| 75 | MP0004233_abnormal_muscle_weight | 1.16594007 |
| 76 | MP0002938_white_spotting | 1.16436469 |
| 77 | MP0004185_abnormal_adipocyte_glucose | 1.15791898 |
| 78 | MP0002108_abnormal_muscle_morphology | 1.15452158 |
| 79 | MP0005503_abnormal_tendon_morphology | 1.13520212 |
| 80 | MP0001299_abnormal_eye_distance/ | 1.12281561 |
| 81 | MP0005375_adipose_tissue_phenotype | 1.12098153 |
| 82 | MP0003119_abnormal_digestive_system | 1.11269852 |
| 83 | MP0002127_abnormal_cardiovascular_syste | 1.10317850 |
| 84 | MP0004742_abnormal_vestibular_system | 1.10192248 |
| 85 | MP0004133_heterotaxia | 1.08889297 |
| 86 | * MP0002882_abnormal_neuron_morphology | 1.07798951 |
| 87 | MP0002090_abnormal_vision | 1.07787546 |
| 88 | MP0008438_abnormal_cutaneous_collagen | 1.05951598 |
| 89 | MP0003937_abnormal_limbs/digits/tail_de | 1.05709210 |
| 90 | MP0010630_abnormal_cardiac_muscle | 1.04371028 |
| 91 | MP0000003_abnormal_adipose_tissue | 1.03848525 |
| 92 | MP0000631_abnormal_neuroendocrine_gland | 1.03219003 |
| 93 | MP0003136_yellow_coat_color | 1.02478758 |
| 94 | MP0000750_abnormal_muscle_regeneration | 1.02189112 |
| 95 | MP0005379_endocrine/exocrine_gland_phen | 1.01816519 |
| 96 | MP0002822_catalepsy | 1.01508823 |
| 97 | MP0002234_abnormal_pharynx_morphology | 0.98807727 |
| 98 | MP0005645_abnormal_hypothalamus_physiol | 0.98010510 |
| 99 | * MP0002066_abnormal_motor_capabilities/c | 0.97137795 |
| 100 | MP0005171_absent_coat_pigmentation | 0.96752519 |
| 101 | MP0001968_abnormal_touch/_nociception | 0.95884187 |
| 102 | MP0005623_abnormal_meninges_morphology | 0.93982092 |
| 103 | MP0000955_abnormal_spinal_cord | 0.93705137 |
| 104 | MP0001905_abnormal_dopamine_level | 0.92633747 |
| 105 | MP0001502_abnormal_circadian_rhythm | 0.92213517 |
| 106 | MP0002735_abnormal_chemical_nociception | 0.92169799 |
| 107 | MP0001501_abnormal_sleep_pattern | 0.91170014 |
| 108 | MP0000569_abnormal_digit_pigmentation | 0.90984385 |
| 109 | MP0001970_abnormal_pain_threshold | 0.90841461 |
| 110 | MP0001944_abnormal_pancreas_morphology | 0.89741080 |
| 111 | MP0001485_abnormal_pinna_reflex | 0.89431124 |
| 112 | MP0003633_abnormal_nervous_system | 0.88803555 |
| 113 | MP0002184_abnormal_innervation | 0.88511033 |
| 114 | MP0002557_abnormal_social/conspecific_i | 0.88396824 |
| 115 | MP0001661_extended_life_span | 0.88001598 |
| 116 | MP0003890_abnormal_embryonic-extraembry | 0.86817082 |
| 117 | MP0005409_darkened_coat_color | 0.85761557 |
| 118 | MP0002254_reproductive_system_inflammat | 0.85578418 |
| 119 | * MP0002752_abnormal_somatic_nervous | 0.84964528 |
| 120 | MP0003632_abnormal_nervous_system | 0.82664959 |
| 121 | MP0004147_increased_porphyrin_level | 0.81924305 |
| 122 | MP0003631_nervous_system_phenotype | 0.81620117 |
| 123 | * MP0005195_abnormal_posterior_eye | 0.81187019 |
| 124 | MP0000230_abnormal_systemic_arterial | 0.80095712 |
| 125 | MP0002971_abnormal_brown_adipose | 0.78205800 |
| 126 | MP0000462_abnormal_digestive_system | 0.78056807 |
| 127 | MP0003121_genomic_imprinting | 0.77497658 |
| 128 | MP0002733_abnormal_thermal_nociception | 0.77449881 |
| 129 | MP0002736_abnormal_nociception_after | 0.76651863 |
| 130 | MP0005535_abnormal_body_temperature | 0.76602686 |
| 131 | MP0000049_abnormal_middle_ear | 0.76499159 |
| 132 | MP0004272_abnormal_basement_membrane | 0.76308662 |
| 133 | MP0005187_abnormal_penis_morphology | 0.76247198 |
| 134 | MP0005670_abnormal_white_adipose | 0.75861168 |
| 135 | MP0009384_cardiac_valve_regurgitation | 0.75463466 |
| 136 | MP0004510_myositis | 0.75204084 |
| 137 | MP0002163_abnormal_gland_morphology | 0.74482945 |
| 138 | MP0010386_abnormal_urinary_bladder | 0.73833042 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Exercise-induced myalgia (HP:0003738) | 4.53413480 |
| 2 | Muscle hypertrophy of the lower extremities (HP:0008968) | 4.47384226 |
| 3 | Sudden death (HP:0001699) | 4.46309460 |
| 4 | Calf muscle hypertrophy (HP:0008981) | 4.31006756 |
| 5 | Muscle fiber splitting (HP:0003555) | 4.05463349 |
| 6 | Exercise-induced muscle cramps (HP:0003710) | 3.70543558 |
| 7 | Abnormality of the calf musculature (HP:0001430) | 3.70308102 |
| 8 | Hyporeflexia of lower limbs (HP:0002600) | 3.66363043 |
| 9 | Atrial fibrillation (HP:0005110) | 3.60918929 |
| 10 | Central scotoma (HP:0000603) | 3.47241930 |
| 11 | Prolonged QT interval (HP:0001657) | 3.42216528 |
| 12 | Primary atrial arrhythmia (HP:0001692) | 3.37668895 |
| 13 | Difficulty running (HP:0009046) | 3.35658338 |
| 14 | Syncope (HP:0001279) | 3.34631139 |
| 15 | Focal motor seizures (HP:0011153) | 3.23903739 |
| 16 | Neurofibrillary tangles (HP:0002185) | 3.18447761 |
| 17 | Supraventricular tachycardia (HP:0004755) | 3.17698920 |
| 18 | Supraventricular arrhythmia (HP:0005115) | 3.11084359 |
| 19 | Myoglobinuria (HP:0002913) | 3.05195722 |
| 20 | Degeneration of the lateral corticospinal tracts (HP:0002314) | 3.01336344 |
| 21 | Atrophy/Degeneration involving the corticospinal tracts (HP:0007372) | 3.01336344 |
| 22 | EMG: myopathic abnormalities (HP:0003458) | 2.91737262 |
| 23 | Ventricular tachycardia (HP:0004756) | 2.83009797 |
| 24 | Pheochromocytoma (HP:0002666) | 2.81444461 |
| 25 | Congenital stationary night blindness (HP:0007642) | 2.76717175 |
| 26 | Thyroid-stimulating hormone excess (HP:0002925) | 2.71067871 |
| 27 | Scotoma (HP:0000575) | 2.63223411 |
| 28 | Rimmed vacuoles (HP:0003805) | 2.60362524 |
| 29 | Increased variability in muscle fiber diameter (HP:0003557) | 2.58002194 |
| 30 | Renal cortical cysts (HP:0000803) | 2.56317529 |
| 31 | Myokymia (HP:0002411) | 2.56176294 |
| 32 | Hyperinsulinemic hypoglycemia (HP:0000825) | 2.53599987 |
| 33 | Cerebral inclusion bodies (HP:0100314) | 2.51739228 |
| 34 | Myotonia (HP:0002486) | 2.51406682 |
| 35 | Muscle fiber inclusion bodies (HP:0100299) | 2.49886402 |
| 36 | Hyperglycemia (HP:0003074) | 2.49524428 |
| 37 | Abnormality of the corticospinal tract (HP:0002492) | 2.47640370 |
| 38 | Abnormal EKG (HP:0003115) | 2.46796623 |
| 39 | Insulin-resistant diabetes mellitus (HP:0000831) | 2.46222406 |
| 40 | Large for gestational age (HP:0001520) | 2.45806106 |
| 41 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 2.43904938 |
| 42 | Lipoatrophy (HP:0100578) | 2.43415365 |
| 43 | Ventricular fibrillation (HP:0001663) | 2.41344426 |
| 44 | Abnormality of macular pigmentation (HP:0008002) | 2.40984826 |
| 45 | Intestinal atresia (HP:0011100) | 2.39905173 |
| 46 | Neuroendocrine neoplasm (HP:0100634) | 2.38244011 |
| 47 | Bundle branch block (HP:0011710) | 2.37321173 |
| 48 | Hypoglycemic seizures (HP:0002173) | 2.37052131 |
| 49 | Abnormality of the renal cortex (HP:0011035) | 2.36325355 |
| 50 | Nephronophthisis (HP:0000090) | 2.35200573 |
| 51 | Dilated cardiomyopathy (HP:0001644) | 2.34245015 |
| 52 | Type II lissencephaly (HP:0007260) | 2.33420452 |
| 53 | Supranuclear gaze palsy (HP:0000605) | 2.33158383 |
| 54 | Ventricular arrhythmia (HP:0004308) | 2.33026500 |
| 55 | Hemiparesis (HP:0001269) | 2.31747296 |
| 56 | Hypoglycemic coma (HP:0001325) | 2.30477666 |
| 57 | Type 1 muscle fiber predominance (HP:0003803) | 2.30244638 |
| 58 | Focal seizures (HP:0007359) | 2.29526151 |
| 59 | Febrile seizures (HP:0002373) | 2.28447273 |
| 60 | Epileptic encephalopathy (HP:0200134) | 2.28180798 |
| 61 | Subaortic stenosis (HP:0001682) | 2.24421142 |
| 62 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.24421142 |
| 63 | Gowers sign (HP:0003391) | 2.23806974 |
| 64 | * Dysmetria (HP:0001310) | 2.22896514 |
| 65 | Action tremor (HP:0002345) | 2.20599213 |
| 66 | Hypoplastic ischia (HP:0003175) | 2.20403038 |
| 67 | Short hallux (HP:0010109) | 2.17527996 |
| 68 | Aplasia/Hypoplasia of the hallux (HP:0008362) | 2.13983450 |
| 69 | Termporal pattern (HP:0011008) | 2.13941013 |
| 70 | Insidious onset (HP:0003587) | 2.13941013 |
| 71 | Oligomenorrhea (HP:0000876) | 2.13422534 |
| 72 | Abnormality of skeletal muscle fiber size (HP:0012084) | 2.13135932 |
| 73 | Hyperventilation (HP:0002883) | 2.11171646 |
| 74 | Nemaline bodies (HP:0003798) | 2.10944651 |
| 75 | Right ventricular cardiomyopathy (HP:0011663) | 2.09608893 |
| 76 | Broad metatarsal (HP:0001783) | 2.08557412 |
| 77 | Atonic seizures (HP:0010819) | 2.07477525 |
| 78 | Optic nerve hypoplasia (HP:0000609) | 2.07404099 |
| 79 | Scapular winging (HP:0003691) | 2.06148119 |
| 80 | Muscle stiffness (HP:0003552) | 2.05630357 |
| 81 | Scanning speech (HP:0002168) | 2.04468816 |
| 82 | Abnormality of the renal medulla (HP:0100957) | 2.04133686 |
| 83 | Ankle clonus (HP:0011448) | 2.01816748 |
| 84 | Spastic gait (HP:0002064) | 2.00963587 |
| 85 | Neck muscle weakness (HP:0000467) | 2.00496926 |
| 86 | Left ventricular hypertrophy (HP:0001712) | 2.00326935 |
| 87 | Agitation (HP:0000713) | 2.00149010 |
| 88 | Visual hallucinations (HP:0002367) | 1.99715722 |
| 89 | Progressive inability to walk (HP:0002505) | 1.98852478 |
| 90 | Abnormality of endocrine pancreas physiology (HP:0012093) | 1.97584068 |
| 91 | Abnormality of the pancreatic islet cells (HP:0006476) | 1.97584068 |
| 92 | Onion bulb formation (HP:0003383) | 1.97115534 |
| 93 | Aplasia/Hypoplasia of the optic nerve (HP:0008058) | 1.96583627 |
| 94 | Aplasia/Hypoplasia of the pubic bone (HP:0009104) | 1.95919321 |
| 95 | Foot dorsiflexor weakness (HP:0009027) | 1.94670771 |
| 96 | Distal arthrogryposis (HP:0005684) | 1.93972463 |
| 97 | Abnormality of the ischium (HP:0003174) | 1.93449597 |
| 98 | Molar tooth sign on MRI (HP:0002419) | 1.92804641 |
| 99 | Abnormality of midbrain morphology (HP:0002418) | 1.92804641 |
| 100 | Retinal dysplasia (HP:0007973) | 1.92702164 |
| 101 | Bony spicule pigmentary retinopathy (HP:0007737) | 1.91462668 |
| 102 | Pancreatic islet-cell hyperplasia (HP:0004510) | 1.91345483 |
| 103 | Abnormality of glycolysis (HP:0004366) | 1.90889308 |
| 104 | Increased serum pyruvate (HP:0003542) | 1.90889308 |
| 105 | Maternal diabetes (HP:0009800) | 1.89577244 |
| 106 | Acute necrotizing encephalopathy (HP:0006965) | 1.89243323 |
| 107 | Pancreatic cysts (HP:0001737) | 1.88738258 |
| 108 | Increased corneal curvature (HP:0100692) | 1.88027977 |
| 109 | Keratoconus (HP:0000563) | 1.88027977 |
| 110 | Pancreatic fibrosis (HP:0100732) | 1.87264722 |
| 111 | * Gaze-evoked nystagmus (HP:0000640) | 1.86749297 |
| 112 | Late onset (HP:0003584) | 1.86331059 |
| 113 | * Intention tremor (HP:0002080) | 1.86259537 |
| 114 | Morphological abnormality of the middle ear (HP:0008609) | 1.85111550 |
| 115 | Abnormal mitochondria in muscle tissue (HP:0008316) | 1.84876394 |
| 116 | Ketoacidosis (HP:0001993) | 1.84527559 |
| 117 | Abnormality of the foot musculature (HP:0001436) | 1.84431587 |
| 118 | Heart block (HP:0012722) | 1.84340106 |
| 119 | Generalized tonic-clonic seizures (HP:0002069) | 1.83497804 |
| 120 | * Broad-based gait (HP:0002136) | 1.83198161 |
| 121 | Chorioretinal atrophy (HP:0000533) | 1.82315159 |
| 122 | Absent phalangeal crease (HP:0006109) | 1.82232440 |
| 123 | Anxiety (HP:0000739) | 1.82007962 |
| 124 | Genetic anticipation (HP:0003743) | 1.81577478 |
| 125 | Peripheral hypomyelination (HP:0007182) | 1.80907034 |
| 126 | Dyschromatopsia (HP:0007641) | 1.80877153 |
| 127 | Abnormal pancreas size (HP:0012094) | 1.80858246 |
| 128 | Cerebral hemorrhage (HP:0001342) | 1.79770062 |
| 129 | Lower limb muscle weakness (HP:0007340) | 1.79360701 |
| 130 | Rhabdomyolysis (HP:0003201) | 1.79035746 |
| 131 | * Dysdiadochokinesis (HP:0002075) | 1.78425681 |
| 132 | Frequent falls (HP:0002359) | 1.77274427 |
| 133 | Ketosis (HP:0001946) | 1.76843028 |
| 134 | Abolished electroretinogram (ERG) (HP:0000550) | 1.76611117 |
| 135 | Cerebellar dysplasia (HP:0007033) | 1.76513889 |
| 136 | Palpitations (HP:0001962) | 1.76005723 |
| 137 | Asymmetric septal hypertrophy (HP:0001670) | 1.75098623 |
| 138 | Anterior segment dysgenesis (HP:0007700) | 1.73997426 |
| 139 | Inability to walk (HP:0002540) | 1.73924847 |
| 140 | Progressive macrocephaly (HP:0004481) | 1.72675338 |
| 141 | Dialeptic seizures (HP:0011146) | 1.72499102 |
| 142 | Methylmalonic acidemia (HP:0002912) | 1.71083956 |
| 143 | Poor eye contact (HP:0000817) | 1.70401298 |
| 144 | Aplasia/Hypoplasia of the fovea (HP:0008060) | 1.68189065 |
| 145 | Hypoplasia of the fovea (HP:0007750) | 1.68189065 |
| 146 | Progressive cerebellar ataxia (HP:0002073) | 1.66979113 |
| 147 | True hermaphroditism (HP:0010459) | 1.66844551 |
| 148 | Optic disc pallor (HP:0000543) | 1.66179390 |
| 149 | Abnormal atrioventricular conduction (HP:0005150) | 1.65400377 |
| 150 | Absence seizures (HP:0002121) | 1.64969096 |
| 151 | Areflexia of lower limbs (HP:0002522) | 1.64476967 |
| 152 | Proximal amyotrophy (HP:0007126) | 1.63198848 |
| 153 | Cutaneous finger syndactyly (HP:0010554) | 1.62267808 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | FRK | 4.40120762 |
| 2 | STK39 | 4.11569412 |
| 3 | PHKG2 | 3.09162824 |
| 4 | PHKG1 | 3.09162824 |
| 5 | BMPR1B | 2.75770355 |
| 6 | OBSCN | 2.66943517 |
| 7 | OXSR1 | 2.58135236 |
| 8 | WNK4 | 2.42852715 |
| 9 | TNIK | 2.36213286 |
| 10 | TTN | 2.22618739 |
| 11 | ADRBK2 | 2.20536107 |
| 12 | EPHA4 | 2.16418817 |
| 13 | MARK1 | 2.07461500 |
| 14 | WNK3 | 1.93219301 |
| 15 | STK38L | 1.91299702 |
| 16 | PRPF4B | 1.77662999 |
| 17 | NTRK3 | 1.76817051 |
| 18 | WNK1 | 1.76006022 |
| 19 | MUSK | 1.74290377 |
| 20 | MAP4K2 | 1.67066913 |
| 21 | PKN1 | 1.64882742 |
| 22 | EPHB1 | 1.61753252 |
| 23 | CAMK2D | 1.58842623 |
| 24 | DMPK | 1.55622955 |
| 25 | PINK1 | 1.54018247 |
| 26 | PIK3CA | 1.53407479 |
| 27 | PDK4 | 1.48814184 |
| 28 | PDK3 | 1.48814184 |
| 29 | FGFR2 | 1.46437469 |
| 30 | MAP3K4 | 1.46053967 |
| 31 | PAK3 | 1.39701768 |
| 32 | PAK6 | 1.39523105 |
| 33 | LMTK2 | 1.38895178 |
| 34 | BCR | 1.37904867 |
| 35 | MYLK | 1.36238588 |
| 36 | NTRK1 | 1.36001374 |
| 37 | CASK | 1.29318478 |
| 38 | UHMK1 | 1.23674914 |
| 39 | ZAK | 1.20236318 |
| 40 | CAMK2B | 1.15250979 |
| 41 | TAOK3 | 1.15245371 |
| 42 | INSRR | 1.15007605 |
| 43 | CAMK2A | 1.14397705 |
| 44 | MAP3K9 | 1.13350147 |
| 45 | ICK | 1.13279916 |
| 46 | TLK1 | 1.09102682 |
| 47 | ROCK2 | 1.08916565 |
| 48 | PLK2 | 1.05444664 |
| 49 | CDK5 | 1.04325611 |
| 50 | SGK494 | 1.04130174 |
| 51 | SGK223 | 1.04130174 |
| 52 | PRKD1 | 1.01913013 |
| 53 | FLT3 | 1.01100423 |
| 54 | TYRO3 | 1.00579826 |
| 55 | MET | 0.99406590 |
| 56 | MAPKAPK5 | 0.98273400 |
| 57 | TGFBR1 | 0.93482654 |
| 58 | CDK19 | 0.93110025 |
| 59 | PDK2 | 0.90810988 |
| 60 | PNCK | 0.90525644 |
| 61 | MAPKAPK3 | 0.89716558 |
| 62 | MAP2K7 | 0.89444687 |
| 63 | PRKCG | 0.89164519 |
| 64 | PRKCE | 0.88540958 |
| 65 | NUAK1 | 0.88215478 |
| 66 | CAMK1G | 0.87769249 |
| 67 | MAP2K4 | 0.87639222 |
| 68 | KSR2 | 0.86374265 |
| 69 | CAMK2G | 0.85681242 |
| 70 | LATS1 | 0.85563383 |
| 71 | PRKD3 | 0.85039275 |
| 72 | NTRK2 | 0.83528389 |
| 73 | MARK2 | 0.83119576 |
| 74 | MINK1 | 0.83024940 |
| 75 | ERBB3 | 0.82937960 |
| 76 | MAP3K7 | 0.82547573 |
| 77 | ACVR1B | 0.82260046 |
| 78 | MAPK12 | 0.81532407 |
| 79 | PDPK1 | 0.81521508 |
| 80 | NLK | 0.80268537 |
| 81 | ADRBK1 | 0.80048942 |
| 82 | RET | 0.78624273 |
| 83 | CAMK1 | 0.78296116 |
| 84 | NEK6 | 0.78193579 |
| 85 | STK3 | 0.75061853 |
| 86 | CAMKK2 | 0.74201573 |
| 87 | CSNK1G2 | 0.73048225 |
| 88 | MAPK13 | 0.72999187 |
| 89 | CAMK1D | 0.72425145 |
| 90 | PRKCH | 0.70178368 |
| 91 | NME1 | 0.67477557 |
| 92 | STK11 | 0.65458866 |
| 93 | MAP2K1 | 0.65340321 |
| 94 | BCKDK | 0.65305390 |
| 95 | LIMK1 | 0.63318606 |
| 96 | ROCK1 | 0.63300573 |
| 97 | KSR1 | 0.62597942 |
| 98 | CSNK1A1L | 0.62277804 |
| 99 | GRK7 | 0.62182844 |
| 100 | FGR | 0.60228432 |
| 101 | PTK2B | 0.60164362 |
| 102 | SGK2 | 0.60006610 |
| 103 | CSNK1G3 | 0.59803127 |
| 104 | DYRK2 | 0.59281560 |
| 105 | TIE1 | 0.58465121 |
| 106 | PDK1 | 0.57724670 |
| 107 | DDR2 | 0.57446116 |
| 108 | PDGFRB | 0.56763544 |
| 109 | PRKAA2 | 0.56323742 |
| 110 | PDGFRA | 0.56153279 |
| 111 | MKNK2 | 0.55475000 |
| 112 | SGK1 | 0.53656930 |
| 113 | MAP2K2 | 0.53143407 |
| 114 | PRKG1 | 0.52679888 |
| 115 | EPHA3 | 0.52657462 |
| 116 | PRKACA | 0.51861626 |
| 117 | FES | 0.50786828 |
| 118 | PRKACB | 0.50756857 |
| 119 | CAMKK1 | 0.50686073 |
| 120 | CDC42BPA | 0.50498744 |
| 121 | FER | 0.49931340 |
| 122 | TRPM7 | 0.49831189 |
| 123 | CSNK1G1 | 0.49237599 |
| 124 | PRKAA1 | 0.47479476 |
| 125 | CDK14 | 0.46949289 |
| 126 | GRK1 | 0.46597437 |
| 127 | CSNK1D | 0.45995386 |
| 128 | STK24 | 0.45807825 |
| 129 | DAPK2 | 0.45700895 |
| 130 | EPHB2 | 0.40077796 |
| 131 | RPS6KA3 | 0.39634818 |
| 132 | PASK | 0.37222609 |
| 133 | GRK5 | 0.34752817 |
| 134 | STK38 | 0.33626018 |
| 135 | CDK8 | 0.33265404 |
| 136 | MST4 | 0.32348871 |
| 137 | PRKACG | 0.32051748 |

| Rank | Gene Set | Z-score |
|---|---|---|
| 1 | Phototransduction_Homo sapiens_hsa04744 | 2.72133639 |
| 2 | Maturity onset diabetes of the young_Homo sapiens_hsa04950 | 2.53153325 |
| 3 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 2.28589456 |
| 4 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 2.21357969 |
| 5 | Fatty acid elongation_Homo sapiens_hsa00062 | 2.13187021 |
| 6 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 2.11969183 |
| 7 | Synthesis and degradation of ketone bodies_Homo sapiens_hsa00072 | 1.94932562 |
| 8 | GABAergic synapse_Homo sapiens_hsa04727 | 1.94716303 |
| 9 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.87451313 |
| 10 | Propanoate metabolism_Homo sapiens_hsa00640 | 1.85359679 |
| 11 | Retrograde endocannabinoid signaling_Homo sapiens_hsa04723 | 1.82883895 |
| 12 | Circadian entrainment_Homo sapiens_hsa04713 | 1.81536551 |
| 13 | Nicotine addiction_Homo sapiens_hsa05033 | 1.79174533 |
| 14 | Glutamatergic synapse_Homo sapiens_hsa04724 | 1.78452563 |
| 15 | Morphine addiction_Homo sapiens_hsa05032 | 1.72432645 |
| 16 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 1.61992053 |
| 17 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 1.61127859 |
| 18 | Terpenoid backbone biosynthesis_Homo sapiens_hsa00900 | 1.58460913 |
| 19 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 1.57877713 |
| 20 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 1.49725389 |
| 21 | Butanoate metabolism_Homo sapiens_hsa00650 | 1.45725754 |
| 22 | Olfactory transduction_Homo sapiens_hsa04740 | 1.43083025 |
| 23 | Salivary secretion_Homo sapiens_hsa04970 | 1.42672666 |
| 24 | Renin secretion_Homo sapiens_hsa04924 | 1.42059830 |
| 25 | Fatty acid metabolism_Homo sapiens_hsa01212 | 1.40424885 |
| 26 | Gastric acid secretion_Homo sapiens_hsa04971 | 1.40215467 |
| 27 | Tryptophan metabolism_Homo sapiens_hsa00380 | 1.37661231 |
| 28 | Alzheimers disease_Homo sapiens_hsa05010 | 1.37151387 |
| 29 | Parkinsons disease_Homo sapiens_hsa05012 | 1.35341027 |
| 30 | Synaptic vesicle cycle_Homo sapiens_hsa04721 | 1.35205680 |
| 31 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.33792562 |
| 32 | Valine, leucine and isoleucine degradation_Homo sapiens_hsa00280 | 1.32403797 |
| 33 | Long-term potentiation_Homo sapiens_hsa04720 | 1.32058057 |
| 34 | Cholinergic synapse_Homo sapiens_hsa04725 | 1.30900562 |
| 35 | Dopaminergic synapse_Homo sapiens_hsa04728 | 1.29545599 |
| 36 | Serotonergic synapse_Homo sapiens_hsa04726 | 1.29511945 |
| 37 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 1.28965973 |
| 38 | Insulin secretion_Homo sapiens_hsa04911 | 1.26547026 |
| 39 | Calcium signaling pathway_Homo sapiens_hsa04020 | 1.26147827 |
| 40 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.23331460 |
| 41 | Endocrine and other factor-regulated calcium reabsorption_Homo sapiens_hsa04961 | 1.21517642 |
| 42 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 1.19507768 |
| 43 | Protein export_Homo sapiens_hsa03060 | 1.19430680 |
| 44 | Axon guidance_Homo sapiens_hsa04360 | 1.18473073 |
| 45 | Mucin type O-Glycan biosynthesis_Homo sapiens_hsa00512 | 1.17309851 |
| 46 | Long-term depression_Homo sapiens_hsa04730 | 1.14615779 |
| 47 | Amphetamine addiction_Homo sapiens_hsa05031 | 1.13388898 |
| 48 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 1.11811758 |
| 49 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 1.11792586 |
| 50 | Glycosaminoglycan biosynthesis - keratan sulfate_Homo sapiens_hsa00533 | 1.08401442 |
| 51 | Biosynthesis of unsaturated fatty acids_Homo sapiens_hsa01040 | 1.07519141 |
| 52 | Taste transduction_Homo sapiens_hsa04742 | 1.05392560 |
| 53 | Fatty acid degradation_Homo sapiens_hsa00071 | 1.04023202 |
| 54 | Aldosterone synthesis and secretion_Homo sapiens_hsa04925 | 1.03495327 |
| 55 | Alanine, aspartate and glutamate metabolism_Homo sapiens_hsa00250 | 1.02864674 |
| 56 | alpha-Linolenic acid metabolism_Homo sapiens_hsa00592 | 1.02361621 |
| 57 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.02283888 |
| 58 | cAMP signaling pathway_Homo sapiens_hsa04024 | 1.00759511 |
| 59 | Linoleic acid metabolism_Homo sapiens_hsa00591 | 0.99481832 |
| 60 | Taurine and hypotaurine metabolism_Homo sapiens_hsa00430 | 0.98345856 |
| 61 | Basal cell carcinoma_Homo sapiens_hsa05217 | 0.96668620 |
| 62 | Glycosphingolipid biosynthesis - lacto and neolacto series_Homo sapiens_hsa00601 | 0.96655608 |
| 63 | Hedgehog signaling pathway_Homo sapiens_hsa04340 | 0.95656096 |
| 64 | Cocaine addiction_Homo sapiens_hsa05030 | 0.91468995 |
| 65 | Gap junction_Homo sapiens_hsa04540 | 0.90824544 |
| 66 | Vasopressin-regulated water reabsorption_Homo sapiens_hsa04962 | 0.88173669 |
| 67 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.87575618 |
| 68 | Pancreatic secretion_Homo sapiens_hsa04972 | 0.86965970 |
| 69 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.86846502 |
| 70 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.86493832 |
| 71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86076302 |
| 72 | Aldosterone-regulated sodium reabsorption_Homo sapiens_hsa04960 | 0.84846502 |
| 73 | GnRH signaling pathway_Homo sapiens_hsa04912 | 0.84126130 |
| 74 | Fatty acid biosynthesis_Homo sapiens_hsa00061 | 0.78388307 |
| 75 | Glycerolipid metabolism_Homo sapiens_hsa00561 | 0.78291497 |
| 76 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.77417770 |
| 77 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 0.76803657 |
| 78 | Hippo signaling pathway_Homo sapiens_hsa04390 | 0.75438029 |
| 79 | Regulation of autophagy_Homo sapiens_hsa04140 | 0.75255529 |
| 80 | Proximal tubule bicarbonate reclamation_Homo sapiens_hsa04964 | 0.74315571 |
| 81 | Tight junction_Homo sapiens_hsa04530 | 0.73865090 |
| 82 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.71974519 |
| 83 | Selenocompound metabolism_Homo sapiens_hsa00450 | 0.71179339 |
| 84 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.70875286 |
| 85 | ECM-receptor interaction_Homo sapiens_hsa04512 | 0.70486388 |
| 86 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.68587274 |
| 87 | Basal transcription factors_Homo sapiens_hsa03022 | 0.68098651 |
| 88 | Ascorbate and aldarate metabolism_Homo sapiens_hsa00053 | 0.66189463 |
| 89 | Inflammatory mediator regulation of TRP channels_Homo sapiens_hsa04750 | 0.65395087 |
| 90 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.65117608 |
| 91 | Neuroactive ligand-receptor interaction_Homo sapiens_hsa04080 | 0.63360440 |
| 92 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.62760464 |
| 93 | Cell adhesion molecules (CAMs)_Homo sapiens_hsa04514 | 0.62257190 |
| 94 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.61953917 |
| 95 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.61822690 |
| 96 | Vitamin B6 metabolism_Homo sapiens_hsa00750 | 0.61771611 |
| 97 | Huntingtons disease_Homo sapiens_hsa05016 | 0.61600717 |
| 98 | Signaling pathways regulating pluripotency of stem cells_Homo sapiens_hsa04550 | 0.60175212 |
| 99 | Sulfur metabolism_Homo sapiens_hsa00920 | 0.59245036 |
| 100 | Glucagon signaling pathway_Homo sapiens_hsa04922 | 0.58684191 |
| 101 | Focal adhesion_Homo sapiens_hsa04510 | 0.58680927 |
| 102 | Glycosylphosphatidylinositol(GPI)-anchor biosynthesis_Homo sapiens_hsa00563 | 0.58673497 |
| 103 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.58643168 |
| 104 | Carbon metabolism_Homo sapiens_hsa01200 | 0.58334982 |
| 105 | Retinol metabolism_Homo sapiens_hsa00830 | 0.57737482 |
| 106 | ErbB signaling pathway_Homo sapiens_hsa04012 | 0.57277013 |
| 107 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.57271542 |
| 108 | ABC transporters_Homo sapiens_hsa02010 | 0.55918265 |
| 109 | Ras signaling pathway_Homo sapiens_hsa04014 | 0.55568290 |
| 110 | PPAR signaling pathway_Homo sapiens_hsa03320 | 0.55061683 |
| 111 | Peroxisome_Homo sapiens_hsa04146 | 0.54545992 |
| 112 | TGF-beta signaling pathway_Homo sapiens_hsa04350 | 0.53563795 |
| 113 | Melanogenesis_Homo sapiens_hsa04916 | 0.52872753 |
| 114 | RNA degradation_Homo sapiens_hsa03018 | 0.52741977 |
| 115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.51446069 |
| 116 | Glyoxylate and dicarboxylate metabolism_Homo sapiens_hsa00630 | 0.51321609 |
| 117 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.50489162 |
| 118 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.49407217 |
| 119 | Lysine degradation_Homo sapiens_hsa00310 | 0.49058373 |
| 120 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.48827962 |
| 121 | Thyroid hormone synthesis_Homo sapiens_hsa04918 | 0.48705701 |
| 122 | Choline metabolism in cancer_Homo sapiens_hsa05231 | 0.47760750 |
| 123 | Estrogen signaling pathway_Homo sapiens_hsa04915 | 0.46979824 |
| 124 | Circadian rhythm_Homo sapiens_hsa04710 | 0.46969500 |
| 125 | Glycosaminoglycan biosynthesis - heparan sulfate / heparin_Homo sapiens_hsa00534 | 0.46882075 |
| 126 | Longevity regulating pathway - multiple species_Homo sapiens_hsa04213 | 0.45420999 |
| 127 | Insulin resistance_Homo sapiens_hsa04931 | 0.42302453 |
| 128 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.41231211 |
| 129 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 0.40956257 |
| 130 | MAPK signaling pathway_Homo sapiens_hsa04010 | 0.40927727 |
| 131 | Protein digestion and absorption_Homo sapiens_hsa04974 | 0.40850354 |
| 132 | Glycerophospholipid metabolism_Homo sapiens_hsa00564 | 0.38560588 |

